Inventor
VAKKALANKA SWAROOP KUMAR V S
CH16 patents
⚠️ This page may combine multiple inventors who share the name “VAKKALANKA SWAROOP KUMAR V S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RHIZEN PHARMACEUTICALS SA
8 patentsUS9150579B2Oct 6, 2015
Selective PI3K delta inhibitors
RHIZEN PHARMACEUTICALS SA34 citations97
US9669033B2Jun 6, 2017
Selective PI3K delta inhibitors
RHIZEN PHARMACEUTICALS SA10 citations92
US9475818B2Oct 25, 2016
Selective PI3K delta inhibitors
RHIZEN PHARMACEUTICALS SA17 citations92
US10072013B2Sep 11, 2018
Selective PI3K delta inhibitors
RHIZEN PHARMACEUTICALS SA9 citations84
US9018375B2Apr 28, 2015
Substituted chromenes as kinase modulators
RHIZEN PHARMACEUTICALS SA8 citations83
US8921364B2Dec 30, 2014
Modulators of calcium release-activated calcium channel
RHIZEN PHARMACEUTICALS SA7 citations82
US8377970B2Feb 19, 2013
Modulators of calcium release-activated calcium channel
RHIZEN PHARMACEUTICALS SA7 citations82
US10174034B2Jan 8, 2019
Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
RHIZEN PHARMACEUTICALS SA0 citations47
MUTHUPPALANIAPPAN MEYYAPPAN
5 patentsUS8642607B2Feb 4, 2014
4H-chromen-4-one compounds as modulators of protein kinases
MUTHUPPALANIAPPAN MEYYAPPAN17 citations91
US8481739B2Jul 9, 2013
3,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinases
MUTHUPPALANIAPPAN MEYYAPPAN7 citations83
US8993612B2Mar 31, 2015
Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
MUTHUPPALANIAPPAN MEYYAPPAN6 citations79
US10442783B2Oct 15, 2019
2,3-disubstituted chromen-4-one compounds as modulators of protein kinases
MUTHUPPALANIAPPAN MEYYAPPAN0 citations51
US8686048B2Apr 1, 2014
Immunomodulator and anti-inflammatory compounds
MUTHUPPALANIAPPAN MEYYAPPAN1 citations50